Human Microbiome Clostridia-Derived Biosynthetic Enzymes/Pathways for the Biological Production of Natural and Non-Natural Fatty Acylated Compounds
Invention type: Technology
/
Case number: #20961
Disclosed herein, in some embodiments, are vectors encoding biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes), engineered cells comprising the vectors, and methods of using biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes) to produce fatty acid amides.
Researchers
Christopher Voigt
/ Fang-Yuan Chang
Departments: Department of Biological Engineering
Technology Areas: Biotechnology: Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis / Drug Delivery: Vectors & Virus like Particles
Impact Areas: Healthy Living
-
human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides
United States of America | Granted | 11,441,162 -
human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.